Background
==========

Smoking cessation is crucial for a better prognosis in patients with coronary heart disease (CHD)[@b1-copd-11-1453]--[@b3-copd-11-1453] and COPD.[@b2-copd-11-1453],[@b4-copd-11-1453],[@b5-copd-11-1453] Acute heart attacks are associated with high smoking cessation rates. In patients with a first myocardial infarction (MI) in the 1970s,[@b3-copd-11-1453] among whom 78% were smoking, the quitting rate was 55%. In a systematic review from 2003, the mean rate of smoking cessation within a year after a new diagnosis of CHD was found to be 45%.[@b1-copd-11-1453] A lower quitting rate was observed in patients with COPD, in particular in subjects not participating in smoking cessation programs. Among smoking COPD patients in a Swedish study, 10% of those receiving usual care had stopped smoking after 3 years, compared to 38% of those who took part in smoking cessation groups.[@b6-copd-11-1453] Among hospitalized patients with respiratory and cardiac diseases who took part in an intensive smoking cessation program in Singapore, 60% of the cardiac patients and 40% of the respiratory patients were still abstinent from smoking after 2 months.[@b7-copd-11-1453]

The mortality due to CHD has decreased considerably in the Western world in the last few decades.[@b8-copd-11-1453] Evidence shows that decreased smoking prevalence in the general population, particularly among patients with heart disease, is an important reason for this decrease.[@b8-copd-11-1453]--[@b11-copd-11-1453] The mortality due to COPD has decreased less.[@b12-copd-11-1453] A stronger tendency of persistent smoking among COPD patients may partly explain this difference.

COPD patients' reluctance to quit smoking may lead to a feeling of hopelessness among the doctors who treat them.[@b13-copd-11-1453] Our aim was to determine how the quitting rate in adults is influenced by getting a diagnosis of obstructive lung disease in the population-based Tromsø study. We also wanted to investigate whether influence from this life event differs from being diagnosed with CHD.

Methods
=======

Subjects
--------

A large proportion of the adult population in Tromsø has participated in health surveys (the Tromsø study) since 1974. Tromsø is a university city in northern Norway with \~72,600 inhabitants. The Tromsø study so far consists of six surveys, and this study deals with subjects who participated in both Tromsø 5 (2001--2002) and Tromsø 6 (2007--2008). The attendance rates (of those invited) in Tromsø 5 and Tromsø 6 were 79% and 66%, respectively. Details of the participants have previously been described.[@b14-copd-11-1453] We included participants who answered the questions on smoking in both surveys. No smoking cessation support was offered during the surveys.

The Regional committee for Medical and Health Research Ethics and the Norwegian Data Inspectorate approved the Tromsø 5 and Tromsø 6 surveys with a license for further analysis on non-identifiable data, like this study. All the participants gave written informed consent.

Examinations
------------

In both surveys, the invitation included a questionnaire with questions on smoking habits, education, and diseases. We classified subjects reporting daily smoking in Tromsø 5, but not in Tromsø 6, as quitters. We divided length of education into three categories, ≤12 years, 13--16 years, and ≥17 years. [Table 1](#t1-copd-11-1453){ref-type="table"} shows the reported diseases. For each disease in the questionnaire the participants were asked whether they have or have had the disease in question. We classified diseases reported in Tromsø 6 and not in Tromsø 5 as new diagnoses. We categorized MI and angina pectoris as "CHD" and asthma and COPD as "obstructive lung disease".

Statistical analysis
--------------------

The frequencies of current smoking at baseline (in Tromsø 5) and smoking cessation among smokers were calculated by subject characteristics, and the statistical differences between subgroups were analyzed by chi-square statistics. We analyzed predictors of smoking cessation by binary logistic regression. Significant variables in univariable analysis (*P*\<0.1), as well as age and sex, were entered in the multivariable analysis. For the statistical analyses, we used the IBM SPSS statistic, Version 21 (IBM Corporation, Armonk, NY, USA).

Results
=======

A total of 4,631 subjects participated in both the fifth and the sixth surveys of the Tromsø study, and 4,497 subjects comprising 1,852 men and 2,645 women answered the questions on smoking in both surveys. The mean time difference between attending the two surveys was 6.2 years (standard deviation 0.5 years). The mean age at Tromsø 5 was 61.1 years (range 30--81 years); 1,150 (25.6%) reported daily smoking and 1,753 (39.0%) reported former smoking. The highest prevalence of smoking (43.8%) was found in subjects with self-reported COPD, whereas the frequency among those with self-reported CHD was 19.0%. The characteristics of the population in Tromsø 5 and the respective frequencies of smoking are listed in [Table 1](#t1-copd-11-1453){ref-type="table"}.

In the sixth survey, 765 subjects (17.0%) reported current smoking, and 428 of the 1,150 who had been smoking in Tromsø 5 had quit (37.2%). A significantly higher quitting rate was found in men compared to women, and the quitting rate increased with the length of education. Self-reported diseases registered in Tromsø 5 had no significant impact on the quitting rate ([Table 2](#t2-copd-11-1453){ref-type="table"}). The number of days between attending the two surveys had no impact on the quitting rate (odds ratio =1, *P*=0.8).

[Table 3](#t3-copd-11-1453){ref-type="table"} shows the frequencies of new self-reported diseases reported in Tromsø 6, but not in Tromsø 5, and the association between a new diagnosis and smoking cessation. New diagnoses of asthma/COPD (n=79) and CHD (n=73) were both associated with increased frequency of quitting, 50.6% (*P*=0.01) and 52.1% (*P*=0.008), respectively. A new diagnosis of asthma/COPD or CHD was reported in 144 subjects. Both men and women belonging to any of these diagnostic groups showed increased quitting rates, 54.9% vs 39.8% (*P*=0.02) in men and 47.1% vs 32.7% (*P*=0.009) in women. The impact of getting these new diagnoses was particularly strong among the subjects with education length no longer than 12 years (*P*=0.001; [Figure 1](#f1-copd-11-1453){ref-type="fig"}). Subjects with education length up to 12 years were also more frequently diagnosed with these diseases compared to those with higher education, 16.0% and 9.5% (*P*=0.01), respectively. Among subjects with higher education, a high quitting rate was independent of a new diagnosis ([Figure 1](#f1-copd-11-1453){ref-type="fig"}).

A new diagnosis of both CHD and obstructive lung disease was significantly associated with smoking cessation when analyzed by logistic regression and also after adjusting for sex and education level in multivariable logistic regression analyses ([Table 4](#t4-copd-11-1453){ref-type="table"}).

Discussion
==========

Main findings
-------------

Half of the participants with a new diagnosis of asthma/COPD or angina/MI quit smoking during the 6 years of follow-up. However, the association between these new diagnoses and smoking cessation was found only in participants with education length up to 12 years. The much higher smoking rate among those with asthma and, in particular, those with COPD at baseline than in those with CHD indicates a shift in attitude toward smoking cessation among subjects with COPD.

Strengths and limitations
-------------------------

The high number of participants and the high attendance rates among those invited are strengths of the study. The prevalences of daily smoking among all the attendees in Tromsø 5 and Tromsø 6 were 31% and 22%, respectively,[@b11-copd-11-1453] which are close to the national prevalences of 29% and 21%, as registered by Statistics Norway (<https://www.ssb.no>)[@b15-copd-11-1453] in 2002 and 2008, respectively. In our study sample, the prevalence was lower at both points of time, 25.6% and 17.0%, respectively, and a healthy survivor effect may have contributed to the low frequency of daily smoking in our subsample. The study is based on questionnaires and not on objective measurements of smoking, such as cotinine and thiocyanate. In a previous Norwegian study, self-reported smoking was strongly related to serum thiocyanate if the question was asked in a neutral setting.[@b16-copd-11-1453] Although the questions on smoking were included in a self-administered questionnaire, underreporting of daily smoking among those with a new diagnosis cannot be ruled out.

All diagnoses were self-reported, and their correctness could not be confirmed. Shift in diagnosis based on the same illness from Tromsø 5 to Tromsø 6, for instance, between asthma and COPD, may have taken place in some subjects. Such a change has been counted as a new diagnosis. This is no longer a problem when asthma and COPD are combined into one category (asthma and/or COPD) and subjects with a new diagnosis of any of these diseases are compared with those with neither of the diagnoses at both Tromsø 5 and Tromsø 6.

Although we have found associations between a new diagnosis and smoking cessation, we do not know for sure whether the extra cessations in the subgroups with a new diagnosis were really preceded by a new diagnosis. Subjects in these subgroups could have stopped smoking before the diagnosis was given. In these cases, it is likely that symptoms from a pulmonary or heart disease had raised their awareness of the risk of continued smoking.

Comparisons with previous studies
---------------------------------

No previous study has, to our knowledge, described smoking cessation in relation to a new diagnosis of heart or lung disease. Most previous studies evaluated smoking cessation programs, and control groups in such studies can be compared with our participants. However, the quitting rate of 41.7% among subjects with a COPD diagnosis reported in Tromsø 5 was more similar to the rate of 38% among the COPD patients, who had taken part in the smoking cessation program in a Swedish study, than the rate of 10% among the COPD patients on usual care.[@b6-copd-11-1453] In a study from primary care, where smokers received smoking cessation advice and were followed up annually with spirometry, higher rates of abstinence were found among those with COPD than among those with normal lung function.[@b17-copd-11-1453] This result is in line with our findings. We found that the quitting rate increased with increasing length of education, and this association is well known from previous studies.[@b18-copd-11-1453]

Qualitative studies have shown that patients with a COPD diagnosis may have several reasons for not quitting despite the knowledge of harming themselves,[@b19-copd-11-1453] and they do not always believe that quitting would give them a better life.[@b20-copd-11-1453] COPD patients often show little interest in receiving help from medication and describe unassisted quitting as the best method to stop smoking, based on willpower, strong motivation, and internal strength.[@b21-copd-11-1453] In our study, a new diagnosis of COPD or CHD might have given many participants the motivation they needed to quit without assistance. In another qualitative study, the interviewees who had stopped smoking emphasized that persons close to them had a strong influence on their decision to quit.[@b22-copd-11-1453] This gives a reason to believe that the decreasing acceptance of smoking in the society also influences COPD patients.

Conclusion
==========

It has been suggested that a hard core of smokers will constitute an increasing proportion of COPD patients who still smoke.[@b23-copd-11-1453] The high quitting rates among subjects with both an established and a new diagnosis of COPD in our study contradicts this pessimism. The study supports pursuit of early diagnosis of COPD and gives reasons for a more optimistic attitude among health workers when they discuss smoking cessation with their COPD patients.
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###### 

Daily smoking according to characteristics of the cohort of 4,497 participants in Tromsø 5 (2001--2002) who also took part in Tromsø 6 (2007--2008)

                                n       Smoking, n (%)   *P*-value[a](#tfn1-copd-11-1453){ref-type="table-fn"}
  ----------------------------- ------- ---------------- -------------------------------------------------------
  Sex                                                    
   Men                          1,852   462 (24.9)       0.4
   Women                        2,645   688 (26.0)       
  Age (years)                                            
   30--49                       671     233 (34.7)       \<0.001[b](#tfn1a-copd-11-1453){ref-type="table-fn"}
   50--69                       2,879   733 (26.8)       
   70--81                       947     144 (15.2)       
  Education                                              
   0--12 years                  3,265   869 (26.6)       \<0.001[b](#tfn1a-copd-11-1453){ref-type="table-fn"}
   13--16 years                 691     168 (24.3)       
   \>16 years                   407     75 (18.4)        
   Not answered                 134     38 (28.3)        
  Self-reported diseases                                 
   Asthma                                                
    Yes                         366     91 (24.9)        0.7
    No                          4,048   1,040 (25.7)     
    Not answered                85      19 (22.3)        
   COPD                                                  
    Yes                         192     84 (43.8)        \<0.001
    No                          4,201   1,036 (24.1)     
    Not answered                104     30 (28.8)        
   Asthma or COPD                                        
    Yes                         482     145 (30.1)       0.02
    No                          3,923   982 (25.1)       
    Not answered                94      23 (24.5)        
   Angina pectoris                                       
    Yes                         314     55 (17.5)        0.001
    No                          4,078   1,072 (26.3)     
    Not answered                105     23 (25.3)        
   MI                                                    
    Yes                         238     53 (22.3)        0.2
    No                          4,168   1,076 (25.8)     
    Not answered                91      21 (23.1)        
   CHD (angina or infarction)                            
    Yes                         442     84 (19.0)        0.001
    No                          3,962   1,046 (26.4)     
    Not answered                93      20 (21.5)        
   Diabetes                                              
    Yes                         137     30 (21.9)        0.3
    No                          4,275   1,099 (25.7)     
    Not answered                85      21 (24.7)        
   Stroke                                                
    Yes                         105     19 (18.1)        0.08
    No                          4,280   1,103 (25.8)     
    Not answered                112     28 (25.0)        

**Notes:**

Statistical significance of difference between subgroups, "not answered" excluded.

Chi-square trend.

**Abbreviations:** MI, myocardial infarction; CHD, coronary heart disease.

###### 

Smoking cessation between 2001--2002 (Tromsø 5) and 2007--2008 (Tromsø 6) according to characteristics of 1,150 smoking participants in Tromsø 5

                                n       Quit smoking, n (%)   *P*-value[a](#tfn3-copd-11-1453){ref-type="table-fn"}
  ----------------------------- ------- --------------------- -------------------------------------------------------
  Sex                                                         
   Men                          462     194 (42.0)            0.006
   Women                        688     234 (34.0)            
  Age (years)                                                 
   30--49                       233     87 (37.7)             0.6[b](#tfn4-copd-11-1453){ref-type="table-fn"}
   50--69                       773     292 (37.8)            
   70--81                       144     49 (34.0)             
  Education                                                   
   0--12 years                  869     300 (34.5)            \<0.001[b](#tfn4-copd-11-1453){ref-type="table-fn"}
   13--16 years                 168     74 (44.0)             
   \>16 years                   75      42 (56.0)             
   Not answered                 38      12 (31.6)             
  Self-reported diseases                                      
   Asthma                                                     
    Yes                         91      26 (28.6)             0.8
    No                          1,040   394 (37.9)            
    Not answered                19      6 (31.6)              
   COPD                                                       
    Yes                         84      35 (41.7)             0.4
    No                          1,036   384 (37.1)            
    Not answered                30      9 (30.0)              
   Asthma or COPD                                             
    Yes                         145     51 (35.2)             0.5
    No                          982     371 (37.8)            
    Not answered                23      6 (26.1)              
   Angina pectoris                                            
    Yes                         55      17 (30.9)             0.3
    No                          1,072   402 (37.5)            
    Not answered                23      9 (39.1)              
   MI                                                         
    Yes                         53      17 (32.1)             0.4
    No                          1,076   403 (37.5)            
    Not answered                21      8 (38.1)              
   CHD (angina or infarction)                                 
    Yes                         84      28 (33.3)             0.3
    No                          1,046   392 (37.5)            
    Not answered                20      8 (40.0)              
   Diabetes                                                   
    Yes                         30      7 (23.3)              0.1
    No                          1,099   412 (37.5)            
    Not answered                21      9 (42.9)              
   Stroke                                                     
    Yes                         19      6 (31.6)              0.6
    No                          1,103   412 (37.4)            
    Not answered                28      10 (35.7)             

**Notes:**

Statistical significance of difference between subgroups, "not answered" excluded.

Chi-square trend.

**Abbreviations:** MI, myocardial infarction; CHD, coronary heart disease.

###### 

Smoking cessation between 2001--2002 (Tromsø 5) and 2007--2008 (Tromsø 6) according to new diagnosis in the same period

                                n       Quit smoking, n (%)   *P*-value[a](#tfn6-copd-11-1453){ref-type="table-fn"}
  ----------------------------- ------- --------------------- -------------------------------------------------------
  New diagnosis                                               
   Asthma                                                     
    Yes                         42      20 (47.6)             0.2
    No                          967     365 (37.7)            
   COPD                                                       
    Yes                         75      36 (48.0)             0.05
    No                          933     342 (36.7)            
   Asthma or COPD                                             
    Yes                         79      40 (50.6)             0.01
    No                          903     331 (36.7)            
   Angina pectoris                                            
    Yes                         33      15 (45.5)             0.3
    No                          1,017   379 (37.3)            
   MI                                                         
    Yes                         58      30 (51.7)             0.02
    No                          995     365 (36.7)            
   CHD (angina or infarction)                                 
    Yes                         73      38 (52.1)             0.008
    No                          955     348 (36.4)            
   Diabetes                                                   
    Yes                         33      12 (34.4)             0.9
    No                          1,035   391 (37.8)            
   Stroke                                                     
    Yes                         37      12 (32.4)             0.5
    No                          1,037   389 (37.5)            

**Notes:**

Statistical significance of difference between participants with a new (possibly combined) diagnosis and participants without a new (possibly combined) diagnosis in Tromsø 5. In each analysis, participants who reported the diagnosis in question in Tromsø 5, and those who have not answered the question on the diagnosis in any of the surveys, have been excluded.

**Abbreviations:** MI, myocardial infarction; CHD, coronary heart disease.

###### 

ORs for smoking cessation between Tromsø 5 (2001--2002) and Tromsø 6 (2007--2008) according to characteristics of 1,024 smoking participants in Tromsø 5 and new diagnosis reported in Tromsø 6

                                    Univariable      Multivariable                    
  --------------------------------- ---------------- --------------- ---------------- ---------
  Age                               1.0 (1.0--1.0)   0.9             1.0 (1.0--1.0)   0.6
  Male sex                          1.4 (1.1--1.8)   0.01            1.4 (1.1--1.8)   0.02
  Education (years)                                                                   
   13--16                           1.5 (1.0--2.1)   0.03            1.6 (1.1--2.2)   0.02
   ≥17                              2.3 (1.4--3.8)   0.001           2.5 (1.5--4.1)   \<0.001
  New diagnosis of CHD              1.7 (1.1--2.8)   0.02            1.7 (1.0--2.9)   0.04
  New diagnosis of asthma or COPD   1.7 (1.1--2.6)   0.02            1.7 (1.1--2.7)   0.02

**Abbreviations:** OR, odds ratio; CHD, coronary heart disease.
